| 市售DPP-4抑制剂类抗糖尿病药物的比较研究 |
| |
| 引用本文： | 王欣,崔立迁.市售DPP-4抑制剂类抗糖尿病药物的比较研究[J].天津药学,2014(2):75-78. |
| |
| 作者姓名： | 王欣 崔立迁 |
| |
| 作者单位： | 天津生物工程职业技术学院;天津市产品质量监督检测技术研究院 |
| |
| 摘 要： | DPP-4抑制剂是近年来上市的一类高效、高选择性抗2型糖尿病药物,通过检索文献,综述已上市的五种DPP-4抑制剂在结构、药代药动、选择性、药物相互作用、副作用等方面的差异.
|
| 关 键 词： | DPP-4抑制剂 2型糖尿病 西格列汀 沙格列汀 维格列汀 利格列汀 阿格列汀 |
Comparison of several marketed DPP-4 inhibitors |
| |
| Wang Xin;Cui Liqian.Comparison of several marketed DPP-4 inhibitors[J].Tianjin Pharmacy,2014(2):75-78. |
| |
| Authors: | Wang Xin;Cui Liqian |
| |
| Institution: | Wang Xin;Cui Liqian;Tianjin Vocational College of Bioengineering;Tianjin Product Quality Inspection Technology Research Institute; |
| |
| Abstract: | DPP - 4 inhibitors, developed in recent years, are a class of anti - diabetes drugs of type 2 diabetes with high effi- ciency and selectivity. By means of summarizing the literatures, differences of five marketed dipeptidyl peptidase - 4 （ DPP - 4 ） inhibitors in structures, dynamic, selectivity, metabolism, and drug- drug interaction were reviewed in this paper. |
| |
| Keywords: | DPP-4 inhibitor type 2 diabetes saxagliptin sitagliptin linagliptin vildagliptin alogliptin |
| 本文献已被 CNKI 维普 等数据库收录！ |
